title: A role for histamine and H2-receptors in opioid antinociception.
abstract: To investigate the role of brain H2-receptors in opioid antinociceptive mechanisms, the effects of several antagonists of histamine H2-receptors were determined on morphine (MOR)-induced antinociception, opioid-mediated footshock-induced antinociception (FSIA) and on other opiate effects in rats. Zolantidine dimaleate (ZOL), the first brain-penetrating H2 antagonist (0.03-1.6 mumol/kg s.c.) caused a dose-related inhibition of MOR antinociception in both the tail-flick and hot-plate tests, with no effect on base-line responding. ZOL also inhibited opioid FISA with a similar potency. MOR-induced locomotor activity was also reduced by ZOL, but no effect was seen on MOR-induced hyperthermia, catalepsy or lethality. ZOL (10(-5) M) was inactive at mu, delta or kappa opioid receptors and showed at least 35-fold higher affinity at the H2-receptor than at receptors for serotonin, dopamine, norepinephrine or acetylcholine in brain. To clarify further the role of H2-receptors in ZOL's antiopiate activity, the potencies of seven structural congeners of ZOL were determined on the H2-receptor and on MOR antinociception. Over 3 orders of magnitude, the rank order of potencies of the compounds for inhibiting MOR antinociception was highly correlated with their potencies as H2 antagonists. Cimetidine, unlike other H2 antagonists, potentiated MOR antinociception, potentiated opioid FSIA and increased brain MOR levels, actions that are not likely to be due to blockade of H2-receptors. These findings strongly suggest that stimulation of opioid receptors leads to antinociception by mechanisms that include activation of brain H2-receptors.
authors.affiliation: Department of Pharmacology and Toxicology, Albany Medical College, New York.
authors.forename: K R
authors.initials: KR
authors.lastname: Gogas
authors.forename: L B
authors.initials: LB
authors.lastname: Hough
authors.forename: N B
authors.initials: NB
authors.lastname: Eberle
authors.forename: R A
authors.initials: RA
authors.lastname: Lyon
authors.forename: S D
authors.initials: SD
authors.lastname: Glick
authors.forename: S J
authors.initials: SJ
authors.lastname: Ward
authors.forename: R C
authors.initials: RC
authors.lastname: Young
authors.forename: M E
authors.initials: ME
authors.lastname: Parsons
mesh_terms: D000698:Analgesia; D000818:Animals; D052160:Benzothiazoles; D002927:Cimetidine / Q000494:pharmacology; D006632:Histamine / Q000502:physiology*; D008297:Male; D009020:Morphine / Q000494:pharmacology*; D050198:Phenoxypropanolamines; D010880:Piperidines / Q000494:pharmacology; D011899:Ranitidine / Q000494:pharmacology; D051381:Rats; D011919:Rats, Inbred Strains; D011970:Receptors, Histamine H2 / Q000502:physiology*; D011957:Receptors, Opioid / Q000187:drug effects; D013844:Thiazoles / Q000494:pharmacology
chemical_list: D052160:Benzothiazoles; D050198:Phenoxypropanolamines; D010880:Piperidines; D011970:Receptors, Histamine H2; D011957:Receptors, Opioid; D013844:Thiazoles; D009020:Morphine; D002927:Cimetidine; D006632:Histamine; D011899:Ranitidine; C055302:zolantidine